Back to search

Article

From Metabolic to Pathologic Complete Response: Case Report of Neoadjuvant Lorlatinib in Stage IIIB ALK-Positive NSCLC Combined with Uniportal VATS

2026-02-22

Abstract excerpt

<title>Abstract</title> <p>While stage IIIB non-small cell lung cancer (NSCLC) is generally considered unresectable, a subset of patients may benefit from neoadjuvant therapy following comprehensive evaluation. We report a 35-year-old non-smoking female diagnosed with stage IIIB (cT1bN2bM0) adenocarcinoma of the left lower lobe with multiple-station mediastinal lymph node metastasis. Based on a multidisciplinary...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b520dff-c50e-5dff-ba84-a81ee976d1e0
DOI
10.21203/rs.3.rs-8711384/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
From Metabolic to Pathologic Complete Response: Case Report of Neoadjuvant Lorlatinib in Stage IIIB ALK-Positive NSCLC Combined with Uniportal VATSDOI 10.21203/rs.3.rs-8711384/v1
Radiomicsmetabolic signature profiles for advanced non-small cell lung cancer with chemoimmunotherapy by reflecting biological function and survivalSemantic proximity
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report.Semantic proximity
Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.Semantic proximity
Combination of baseline PET/CT total metabolic tumor volume, lesion dissemination and TP53 mutations predicts rapid progression of diffuse large B-cell lymphomaSemantic proximity
Association between metabolic activity and molecular alterations in lung adenocarcinoma: Insights from 18F-FDG PET/CT.Semantic proximity
A retrospective study of the efficacy and safety of Almonertinib in the treatment of locally advanced or brain metastatic non-small cell lung cancer with EGFR-positive mutationsSemantic proximity
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.Semantic proximity
[Annual therapeutic advances in advanced non-small cell lung cancer in 2024].Semantic proximity
Select a neighboring publication to make it the new centre.